GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Elevai Labs Inc (NAS:ELAB) » Definitions » ROE % Adjusted to Book Value

ELAB (Elevai Labs) ROE % Adjusted to Book Value : -223.46% (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Elevai Labs ROE % Adjusted to Book Value?

Elevai Labs's ROE % for the quarter that ended in Sep. 2024 was -107.26%. Elevai Labs's PB Ratio for the quarter that ended in Sep. 2024 was 0.48. Elevai Labs's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -223.46%.


Elevai Labs ROE % Adjusted to Book Value Historical Data

The historical data trend for Elevai Labs's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elevai Labs ROE % Adjusted to Book Value Chart

Elevai Labs Annual Data
Trend Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
- - -20.96

Elevai Labs Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - -30.54 -36.58 -53.10 -223.46

Competitive Comparison of Elevai Labs's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Elevai Labs's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elevai Labs's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Elevai Labs's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Elevai Labs's ROE % Adjusted to Book Value falls into.



Elevai Labs ROE % Adjusted to Book Value Calculation

Elevai Labs's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-173.54% / 8.28
=-20.96%

Elevai Labs's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-107.26% / 0.48
=-223.46%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elevai Labs ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Elevai Labs's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Elevai Labs Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
120 Newport Center Drive, Suite. 250, Newport Beach, CA, USA, 92660
Elevai Labs Inc is a California-based physician-dispensed skincare company with a focus on modernizing aesthetic skincare. It has commercialized ELEVAI Exosomes a next-generation, patent-pending technology used in its ELEVAI flagship products.

Elevai Labs Headlines

From GuruFocus